Diagnostics

Microsynth AG

Microsynth (founded in 1989) is a leading company in Europe in the field of DNA/RNA syntheses & analyses. The main activities are divided into the following three business areas:

  1. DNA/RNA SYNTHESES

› DNA/RNA oligonucleotides (unmodified, modified, various purity grades) for various R&D applications
› Primers and probes (e.g. OEM kit production) for molecular diagnostics
› antisense oligonucleotides as well as siRNAs for drug discovery

  1. DNA/RNA ANALYSES AND SEQUENCING

› DNA Sanger sequencing of all types (incl. GMP sequencing)
› Next generation sequencing (de novo & re-sequencing at the genome level, RNA-Seq, metagenome and amplicon sequencing, bioinformatics, etc.)
› PCR, qPCR and digital PCR
› Genotyping (fragment length analysis, cell line characterization, STR marker development, GBS)
› DNA/RNA isolations (all sources, including high-throughput format)

  1. CONTRACT RESEARCH/OUTSOURCING

› Assay establishment & validation (e.g. IVD, animal and food diagnostics)
› Biological testing (e.g. lot release mRNA vaccines)
› Gene editing/gene therapy (e.g. CRISPR on/off target GxP analyses, rAAV characterization)

Microsynth employs >100 people and has branch offices in Germany (Microsynth Seqlab), France (Microsynth France), Austria (Microsynth Austria) and Switzerland (ecogenics). Microsynth is ISO 9001:2015-, ISO 13485:2016- (oligonucleotide synthesis, kit production), ISO/IEC 17025:2017 (STS 0429) - (NGS, Sanger sequencing, fragment length analysis) and GMP certified (Sanger sequencing).

Competences

DNA/RNA Oligo Synthesis, DNA Sequencing, PCR Analysis, Genotyping, Contract Research

Address

Schützenstrasse 15
CH-9436 Balgach

Phone: +41 (0)71 - 722 83 33
Web: www.microsynth.com

Contact

Christof Wunderlin
CO-CEO
E-Mail: christof.wunderlin@microsynth.ch

follow Microsynth on LinkedIn